🪞 Larry Robbins · Glenview
Long-short healthcare.
Hit rate is measured, not predicted: across 2,030 investor-quarters of walk-forward holdout, the name this model ranked first was the investor’s actual next new buy 1.7% of the time, against 0.62% for a name drawn at random from the same board. That is 2.77x chance. The model ranks the whole board; AUC and the rest of the scoring detail are on the how it works page.
Build a basket from the top picks →
🔮 Predicted next buys: quarter ending 2026-09-30
The model orders Larry Robbins · Glenview’s candidates for the next 13F filing. No public confirmation yet. The rate beside each name is the model’s own score rewritten as a measured quantity: how often a name in that position turned out to be the next buy across 2,030 investor-quarters of holdout. Picking at random from this board lands 0.62%.
| # | Ticker | Company | Measured hit rate | vs base |
|---|---|---|---|---|
| 1 | COO | Cooper Cos Inc/The | 1.7% | 2.8x |
| 2 | DHI | Dr Horton Inc | 1.7% | 2.8x |
| 3 | RRC | Range Resources Corp | 1.7% | 2.7x |
| 4 | MCHP | Microchip Technology Inc | 1.7% | 2.7x |
| 5 | ABT | Abbott Laboratories | 1.6% | 2.6x |
| 6 | DT | Dynatrace Inc | 1.6% | 2.6x |
| 7 | ICE | Intercontinental Exchange In | 1.6% | 2.5x |
| 8 | BRKR | Bruker Corp | 1.6% | 2.5x |
| 9 | DVN | Devon Energy Corp | 1.5% | 2.5x |
| 10 | NOW | Servicenow Inc | 1.5% | 2.4x |
📉 Predicted exits, conviction fading
Of Larry Robbins · Glenview’s current disclosed holdings, the names a model flags as most likely to be EXITED or TRIMMED next quarter, before the 13F shows it. Model score (not a calibrated probability), ranked. Holdings as of 2026-06-30.
| Ticker | Company | Weight | Last move | Sell likelihood |
|---|---|---|---|---|
| AMD | Advanced Micro Devices Inc | 3.16% | trimmed last Q | ▲▲ 67 |
| BRKR | Bruker Corp | 0.28% | just entered | ▲▲ 67 |
| DOCN | Digitalocean Hldgs Inc | 0.24% | trimmed last Q | ▲▲ 64 |
| ONTO | Onto Innovation Inc | 1.42% | trimmed last Q | ▲▲ 62 |
| CAH | Cardinal Health Inc | 0.08% | just entered | ▲▲ 61 |
| PRMB | Primo Brands Corporation | 0.18% | trimmed last Q | ▲▲ 61 |
| TECH | Bio-Techne Corp | 0.08% | trimmed last Q | ▲▲ 61 |
| AMAT | Applied Matls Inc | 0.86% | trimmed last Q | ▲▲ 61 |
⚠️ This predicts the ACTION (whether Larry Robbins · Glenview reduces the position), not a return and not a short. A 13F shows long positions only, so a “sell” here means exiting or cutting a long, never shorting the stock. Walk-forward validated on the decision (AUC ≈ 0.66), but acting on it is not shown to make money. Research, not advice.
📜 Top disclosed holdings: Jun 2026
| Ticker | Company | Weight | Last change |
|---|---|---|---|
| GPN | Global Pmts Inc | 11.77% | ➕ Added |
| CVS | Cvs Health Corp | 9.09% | ➖ Trimmed |
| THC | Tenet Healthcare Corp | 7.62% | ➕ Added |
| TMO | Thermo Fisher Scientific Inc | 5.73% | ➕ Added |
| AMZN | Amazon Com Inc | 5.52% | ➕ Added |
| AG8 | Agilent Technologies Inc | 5.05% | 🆕 New |
| IWM | Ishares Tr | 5.02% | ➕ Added |
| DHR | Danaher Corp Del | 3.97% | ➕ Added |
| META | Meta Platforms Inc | 3.66% | ➕ Added |
| SPY | State Str Spdr S&P 500 Etf T | 3.54% | 🆕 New |
| AMD | Advanced Micro Devices Inc | 3.16% | ➖ Trimmed |
| TEVA | Teva Pharmaceutical Inds Ltd | 3.13% | ➖ Trimmed |
| VTRS | Viatris Inc | 2.86% | ✊ Held |
| UBER | Uber Technologies Inc | 2.36% | ➕ Added |
| CNC | Centene Corp Del | 2.20% | ➖ Trimmed |
Source: SEC Form 13F (public domain), long U.S. equity positions only, disclosed up to 45 days after quarter-end. Top 15 of 44 shown.
💲 Where they bought: accumulation cost
13F shows holdings, not trade prices. Implied average cost is total value ÷ shares; the zone is the price range that quarter, where they accumulated. “vs cost” is today versus that average. This is where they bought, not a future price.
| Ticker | Avg cost | Accumulation zone | Today | vs cost |
|---|---|---|---|---|
| GPN | $72.56 | $62–$75 | $92.74 | +27.8% |
| CVS | $103.45 | $71–$104 | $93.91 | -9.2% |
| THC | $187.08 | $161–$202 | $274.19 | +46.6% |
| TMO | $501.36 | $438–$531 | $630.70 | +25.8% |
| AMZN | $238.34 | $208–$275 | $259.77 | +9.0% |
| IWM | $300.45 | $247–$300 | $293.93 | -2.2% |
| DHR | $190.48 | $162–$198 | $215.36 | +13.1% |
| META | $563.29 | $543–$688 | $571.10 | +1.4% |
| SPY | $746.77 | $649–$758 | $771.10 | +3.3% |
| AMD | $580.91 | $203–$581 | $470.72 | -19.0% |
🎯 Disclosed options: calls vs puts
13F discloses option positions too. Calls lean bullish or levered; puts lean bearish or hedging. This is the not-just-buying side of what they disclose.
| Ticker | Position | Lean |
|---|---|---|
| IWM | puts | bearish / hedge |
| SPY | puts | bearish / hedge |
| AG8 | calls | bullish / levered |
Source: 13F option lines (put_call). Disclosed positions, not advice.
🧬 Factor fingerprint, the style behind the book
76% of Larry Robbins · Glenview’s day-to-day swings are explained by public, buyable factors (Fama-French 5 + momentum), regressed on their current disclosed book (14 of 15 names, ~421 trading days). Market beta 1.01.
⚠️ This is the part the great investors can’t hide: their style is a tilt toward known factors, and every one of these is sold as a cheap index ETF. Buying the factors gets you most of the book for a few basis points. What’s left after the factors (the residual) is noisy on a single concentrated book and is not a reliable edge, read this as transparency about the style you’re copying, not a secret signal. Loadings are in-sample on current static weights, U.S. long positions only. Research, not advice.
📈 This mirror’s track: backtest vs S&P 500
⚠️ Read this honestly. Leak-free walk-forward backtest: top-10 predicted new buys ranked from a broad ~2,000-name universe known at the rebalance date, equal-weight, 1-quarter holds, complete quarters only, gross (before costs). Small samples, per-investor edges are noisy and not statistically significant. The consensus mirror's backtest shows +2.2 pts/quarter net vs the S&P 500 over 35 complete quarters (2017Q3 to 2026Q1), directional, NOT statistically significant (t≈1.3; 95% CI includes zero). Most of that average is one quarter: 2026Q1 posted a +47.5 pt edge, roughly half of it two AI-hardware names (SNDK +258%, AMD +186%) marked at what proved to be a local peak; excluding it the edge is +0.9 pts/quarter. Past performance does not predict future results. Not investment advice.
🔔 Follow this mirror
New filings and predicted-buy refreshes are published to every reader at once, weekly digest (email) · build a basket.
Prior Moves is a research publication: one impersonal model portfolio per investor, identical for every reader. You place any trades yourself at your own broker. No execution, no custody, no individualised advice.